Suven 502 may pass Phase 2 or not.
As far as I know Suven is only Indian company taking initiative in drug discovery ( Correct me if I am wrong)
I strongly feel that Suven 502 should not be monetized after Phase 2, instead it should go through Phase 3 which will give good experience to company.
Suven has strong line of clinical trails. One day it will hit the bull.
Disc: Invested from lower levels
| Subscribe To Our Free Newsletter |
